Transcript שקופית 1

Innovative Minimally Invasive
Circulatory Assist Device
The iVAC 3L
• Minimally invasive circulatory
assist device, provides short term
solution as a bridge to decision or
as a bridge to bridge (LVAD).
• 3 l/m circulatory support in
severe left ventricular failure
and during high-risk
revascularisation procedures.
The Technology
Flexible thin-walled catheter
containing a combined two
way valve connected to a
single port membrane pump
How it works
• During aspiration, blood enters
the catheter through its tip
located at the left ventricular
and is aspirated into the
membrane pump.
• The membrane pump pushes
the blood back in the catheter,
the valve at the side hole opens,
and ejects the blood out
sideways to aorta.
The iVAC 3L Placement
The tip of the catheter is located in the left ventricle and the catheter’s valve in the aorta.
How it works
Indications
Patients with Heart Failure due to left ventricular
low output
•AMI (Heart Attack).
•Cardiogenic Shock.
•Post cardiotomy patients.
•OPCAB (Off Pump Coronary Artery Bypass) - as recovery
support.
•PCI (Percutaneous Cardiac intervention).
Clinical Advantages
• Pulsatile support, pumping synchronized with the heart.
• Increases circulatory blood flow.
• Safe, reliable and easy to use platform technology.
• Fast, subclavian or axillary artery percutaneous insertion.
• Unloading of the left ventricle.
• Increase of coronary and end-organ perfusion.
• Low anticoagulation required; Anti Clotting time - 200 sec.
• Reduction in myocardial workload.
• Low complication rate.
• Reduces risk of hemodynamic deterioration during
High Risk interventions.
Technology Advantages
• Common insertion technique.
• One lumen 21 Fr. Catheter (6.9mm).
• Short straightforward insertion.
• Up to 3 L/min blood flow.
• ECG triggered counter pulsation.
• Driven by standard available IABP consoles.
Thank you